You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cyclin-dependent kinase 2 (CDK2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

    Recruiting
    • Neurofibromatosis 1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Skin Health and Quality of Life in Patients Receiving

    Not yet recruiting
    • Lung Cancer
    • +7 more
    • EQ-5D-5L questionnaire
    • +2 more
    • Roma, Italy
      Roberto Iacovelli
    May 17, 2023

    Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

    Completed
    Has Results
    • Breast Cancer
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 13, 2022

    Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

    Recruiting
    • Breast Cancer
    • CT scans
    • DEXA scan
    • Bronx, New York
      Montefiore Medical Center
    Jan 6, 2023

    Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

    Active, not recruiting
    Has Results
    • Advanced Breast Cancer
    • Beijing, Beijing, China
    • +6 more
    Jun 23, 2022

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023

      Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +2 more
      • CDK Inhibitor AT7519
      • +3 more
      • Washington, District of Columbia
      • +5 more
      Oct 18, 2022

      Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

      Recruiting
      • Chondrosarcoma
      • +2 more
      • Jacksonville, Florida
      • +3 more
      Apr 4, 2022

      Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • (no location specified)
      May 22, 2023

      Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Breast Carcinoma
      • Birmingham, Alabama
      • +12 more
      Feb 17, 2022

      Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

      Not yet recruiting
      • Metastatic Breast Cancer
      • +4 more
      • CDK 4/6 inhibitors
      • Endocrine therapy
      • Helsinki, Finland
      • +11 more
      Sep 19, 2023

      Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

      Not yet recruiting
      • Solid Tumors
      • (no location specified)
      May 17, 2023

      Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

      Not yet recruiting
      • Breast Cancer
      • +8 more
      • (no location specified)
      Feb 9, 2023

      Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

      Recruiting
      • Recurrent Endometrial Carcinoma
      • +3 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Oct 28, 2021

      CDKL5 Deficiency Disorder Trial (Ganaxolone, Placebo)

      Not yet recruiting
      • CDKL5 Deficiency Disorder
      • (no location specified)
      Feb 18, 2022

      Tumors, Breast Tumors Trial in Japan (PD-0332991, letrozole)

      Completed
      Has Results
      • Neoplasms
      • Breast Neoplasms
      • Nagoya, Aichi, Japan
      • +15 more
      Oct 28, 2020

      Toxicity Data in Advanced Breast Cancer Treated With CDK

      Completed
      • Breast Cancer Stage IV
        • Athens, Greece
          Hellenic Oncology Cooperative Group
        Feb 11, 2021

        Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

        Not yet recruiting
        • Breast Cancer
        • +5 more
        • (no location specified)
        Sep 9, 2022

        Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

        Not yet recruiting
        • Aggressive B-Cell Non-Hodgkin's Lymphoma
        • +4 more
        • (no location specified)
        Dec 16, 2022

        Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant

        Withdrawn
        • Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
        • +3 more
        • (no location specified)
        Oct 13, 2021

        Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

        Completed
        Has Results
        • Adult Solid Tumor
        • +38 more
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of The University of Pennsylvania
        Feb 18, 2021

        Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

        Not yet recruiting
        • Breast Cancer
        • +5 more
        • (no location specified)
        Jun 7, 2023